The PillCam SB has been cleared since 2001 for the visualization of the small bowel mucosa and may be used as a tool in the detection of abnormalities of the small bowel in adults and children. The updated FDA approval supports the use of PillCam for the visualization of lesions in a variety of important conditions, such as Crohn’s disease, iron deficiency anemia and obscure gastrointestinal bleeding.
Read the news release about PillCam SB.
Read other coverage about GI devices:
– Healthmark Industries Announces Availability of Product to Help Ensure Safe Endoscope Storage
– Mayo Clinic Gastroenterologist Details Role of Endoscopic Imaging in Small Bowel
– Use of NSAIDs Should be Determined Before Interpreting Capsule Endoscopy Findings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.